Kim SH - Search Results

1

The Inhibitory Effect of Alisol A 24-Acetate from Alisma canaliculatum on Osteoclastogenesis.

Kim KJ, Leutou AS, Yeon JT, Choi SW, Kim SH, Yee ST, Choi KH, Nam SJ, Son YJ. Kim KJ, et al. Among authors: kim sh. Int J Endocrinol. 2015;2015:132436. doi: 10.1155/2015/132436. Epub 2015 Jul 27. Int J Endocrinol. 2015. PMID: 26273291 Free PMC article.

2

Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression.

Kwak HB, Lee BK, Oh J, Yeon JT, Choi SW, Cho HJ, Lee MS, Kim JJ, Bae JM, Kim SH, Kim HS. Kwak HB, et al. Among authors: kim jj, kim sh, kim hs. Bone. 2010 Mar;46(3):724-31. doi: 10.1016/j.bone.2009.10.042. Epub 2009 Nov 6. Bone. 2010. PMID: 19900598

3

Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways.

Choi SW, Son YJ, Yun JM, Kim SH. Choi SW, et al. Among authors: kim sh. Evid Based Complement Alternat Med. 2012;2012:810563. doi: 10.1155/2012/810563. Epub 2012 Sep 12. Evid Based Complement Alternat Med. 2012. PMID: 23008743 Free PMC article.

4

Insulin related compounds and identification.

Min CK, Lee JW, Kim CK, Kim SH, Lee SY, Lee SM, Son YJ. Min CK, et al. Among authors: kim sh, kim ck. J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Nov 1;908:105-12. doi: 10.1016/j.jchromb.2012.08.028. Epub 2012 Sep 16. J Chromatogr B Analyt Technol Biomed Life Sci. 2012. PMID: 23044006

5

Anti-metastatic effect of cantharidin in A549 human lung cancer cells.

Kim YM, Ku MJ, Son YJ, Yun JM, Kim SH, Lee SY. Kim YM, et al. Among authors: kim sh. Arch Pharm Res. 2013 Apr;36(4):479-84. doi: 10.1007/s12272-013-0044-3. Epub 2013 Feb 23. Arch Pharm Res. 2013. PMID: 23435912

6

Antiresorptive activity of bacillus-fermented antler extracts: inhibition of osteoclast differentiation.

Choi SW, Moon SH, Yang HJ, Kwon DY, Son YJ, Yu R, Kim YS, Kim SI, Chae EJ, Park SJ, Kim SH. Choi SW, et al. Among authors: kim sh, kim si, kim ys. Evid Based Complement Alternat Med. 2013;2013:748687. doi: 10.1155/2013/748687. Epub 2013 Feb 10. Evid Based Complement Alternat Med. 2013. PMID: 23509596 Free PMC article.

7

CK2 inhibitor CX4945 induces sequential inactivation of proteins in the signaling pathways related with cell migration and suppresses metastasis of A549 human lung cancer cells.

Ku MJ, Park JW, Ryu BJ, Son YJ, Kim SH, Lee SY. Ku MJ, et al. Among authors: kim sh. Bioorg Med Chem Lett. 2013 Oct 15;23(20):5609-13. doi: 10.1016/j.bmcl.2013.08.043. Epub 2013 Aug 17. Bioorg Med Chem Lett. 2013. PMID: 24012124

8

PF-3758309, p21-activated kinase 4 inhibitor, suppresses migration and invasion of A549 human lung cancer cells via regulation of CREB, NF-κB, and β-catenin signalings.

Ryu BJ, Lee H, Kim SH, Heo JN, Choi SW, Yeon JT, Lee J, Lee J, Cho JY, Kim SH, Lee SY. Ryu BJ, et al. Among authors: kim sh. Mol Cell Biochem. 2014 Apr;389(1-2):69-77. doi: 10.1007/s11010-013-1928-8. Epub 2013 Dec 24. Mol Cell Biochem. 2014. PMID: 24366569

9

Anti-osteoclastogenic activity of matairesinol via suppression of p38/ERK-NFATc1 signaling axis.

Choi SW, Park KI, Yeon JT, Ryu BJ, Kim KJ, Kim SH. Choi SW, et al. Among authors: kim kj, kim sh. BMC Complement Altern Med. 2014 Jan 21;14:35. doi: 10.1186/1472-6882-14-35. BMC Complement Altern Med. 2014. PMID: 24444335 Free PMC article.

10

A novel 11β-HSD1 inhibitor improves diabesity and osteoblast differentiation.

Park JS, Bae SJ, Choi SW, Son YH, Park SB, Rhee SD, Kim HY, Jung WH, Kang SK, Ahn JH, Kim SH, Kim KY. Park JS, et al. Among authors: kim hy, kim sh, kim ky. J Mol Endocrinol. 2014 Mar 6;52(2):191-202. doi: 10.1530/JME-13-0177. Print 2014 Apr. J Mol Endocrinol. 2014. PMID: 24444497

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,562 results

Search Page